SEC Form 4 · accession 0001179110-15-010946
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P Southwell
Director
Period of report
Jul 6, 2015
Accepted (ET)
Jul 6, 2015 · 9:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 6, 2015 | M | 15,000 | $10.85 | A | 23,604 | D | |
| Common StockF2 | Jul 6, 2015 | S | 22,904 | $47.50 | D | 700 | D | |
| Common StockF3 | Jul 6, 2015 | S | 700 | $48.22 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $10.85 | Jul 6, 2015 | M | 15,000 | D | — | May 15, 2023 | Common Stock | 15,000 | 15,000 | D |
| Stock Option (right to buy) | $51.00 | holding | — | — | — | Jan 2, 2016 | Jan 1, 2025 | Common Stock | 12,000 | 12,000 | D |
| Stock Option (right to buy) | $27.05 | holding | — | — | — | Jan 28, 2015 | Jan 27, 2024 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (right to buy)F5 | $218.40 | holding | — | — | — | — | Jan 10, 2022 | Common Stock | 110 | 110 | D |
| Stock Option (right to buy)F5 | $490.80 | holding | — | — | — | — | Apr 27, 2021 | Common Stock | 110 | 110 | D |
| Stock Option (right to buy)F5 | $1,149.60 | holding | — | — | — | — | Feb 2, 2020 | Common Stock | 95 | 95 | D |
| Stock Option (right to buy)F5 | $508.80 | holding | — | — | — | — | Oct 7, 2019 | Common Stock | 108 | 108 | D |
| Stock Option (right to buy)F5 | $735.60 | holding | — | — | — | — | Jan 25, 2018 | Common Stock | 83 | 83 | D |
| Stock Option (right to buy)F5 | $626.40 | holding | — | — | — | — | Apr 18, 2017 | Common Stock | 83 | 83 | D |
| Stock Option (right to buy)F5 | $392.40 | holding | — | — | — | — | Mar 1, 2016 | Common Stock | 125 | 125 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person for the primary purpose of diversification.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.13 to $48.09 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $48.16 to $48.27 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4This option was granted on May 15, 2013 and vests over three years, with 8.33% of the shares underlying the option vested on August 15, 2013 and an additional 8.33% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter.
- F5Currently exercisable.